Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Cametor, cetilistat (ATL-962)
print preview
bookmark
share with colleague
General Information
Company
Norgine B.V.
Description
Oral lipase inhibitor
Molecular Target
Lipase
Mechanism of Action
Lipase inhibitor
Latest Stage of Development
Registration
Indication
Obesity
Partner
Takeda Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy